New clinic aims to tackle heart failure and meth addiction together

NCT ID NCT07211724

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study will test a clinic that treats both heart failure and methamphetamine use disorder at the same time. Fifty adults with heart failure and active meth use will receive counseling, incentives for staying clean, and optional addiction medications, plus standard heart failure care. The goal is to see if this combined approach helps patients stay off meth and take their heart medications as prescribed over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
behavioral counseling, contingency management, and optional medications (mirtazapine, bupropion, naltrexone)
What this could lead to
If successful, this integrated care model could improve heart failure outcomes and methamphetamine abstinence in a high-risk group, potentially reducing hospitalizations and deaths.
What could go wrong
This is a small, early pilot study with only 50 participants and no control group, so results may not apply broadly. The intervention is complex and may be difficult to sustain or scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Los Angeles General Medical Center

    Los Angeles, California, 90089, United States

  • University of Southern California, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences

    Los Angeles, California, 90089, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.